| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 10/02/24 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 10/02/24 | 8-K | Current report filing |
|
   |
3 |
| 09/23/24 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
3 | |
| 09/05/24 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 09/05/24 | 8-K | Current report filing |
|
|
9 |
| 08/22/24 | 8-K | Current report filing |
|
|
50 |
| 08/21/24 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
35 | |
| 08/13/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 08/06/24 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
3 | |
| 08/01/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.